The hypoparathyroidism market is estimated to be valued at USD 787.4 Mn in 2025 and is expected to reach USD 1323.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032. https://kumarkislay.livepositively.com/vulvar-cancer-drugs-market-size-and-growth-insights/new=1